XML 29 R16.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 10 - Income Taxes
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Note 10 - Income Taxes

NOTE 10 — Income Taxes

 

Deferred tax benefit at December 31, 2016 is related to the release of valuation allowance against substantially all of the Company's federal and state deferred tax assets as the Company concluded such assets were fully realizable. The need for a valuation allowance requires an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction-by-jurisdiction basis. In making such assessment, significant weight is given to evidence that can be verified objectively. After the consideration of both positive and negative evidence to assess the recoverability of the Company's net deferred tax assets during the 2016 tax year, the Company determined that it was more likely than not the Company would realize the majority of the value of federal and state deferred tax assets given the current certainties regarding the timing of profits and forecasted future profitability. The Company will continue to monitor the likelihood that it will be able to recover the deferred tax assets in the future. The components of income taxes for the periods ended December 31, 2016 and 2015 are as follows: 

 

    Years Ended December 31,
    2016   2015
  Current:        
  Federal   $ 12,200     $ —    
  State     37,000       —    
       Total Current     49,200       —    
  Deferred:                
  Federal     (8,473,481 )     31,940  
  State     (1,291,140 )     —    
       Total Deferred     (9,764,621 )     31,940  
Income tax (benefit) expense   $ (9,715,421 )   $ 31,940  

 

Reconciliation of the statutory federal income tax rate to the Company's effective tax rate:

 

 

    Years Ended December 31,
    2016   2015
  Federal tax at statutory rate     34.00 %     34.00 %
  State income tax rate     5.83 %     5.83 %
  Release of valuation allowance     308.63 %     (41.56 %)
  Provision for taxes     348.46 %     (1.73 %)

 

 

As of December 31, 2016, the Company did not recognize deferred tax assets relating to an excess tax benefit for stock-based compensation deduction of $2,094,000. Unrecognized deferred tax benefits will be accounted for as a credit to additional-paid-in-capital when realized through a reduction in income taxes payable.

 

Deferred income tax reflects the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amount used for income tax purposes. At December 31, 2016, the Company released valuation allowance against substantially all deferred tax assets. Significant components of net deferred tax assets are as follows: 

 

    Years Ended December 31,
Deferred tax assets:   2016   2015
  Net operating loss carryforwards   $ 8,111,000     $ 8,833,000  
  Credits     755,000       753,000  
  Capitalized research and development costs     9,000       13,000  
  Other acquired intangibles     49,000       91,000  
  Accruals not currently deductible     1,343,000       1,614,000  
  Depreciation     29,000       5,000  
     Total deferred tax assets     10,296,000       11,309,000  
  Valuation allowance for deferred tax assets     (464,000 )     (11,279,000 )
     Net deferred tax assets     9,832,000       30,000  
Deferred tax liability:                
  Acquired intangibles     (243,000 )     (205,000 )
Net deferred tax assets (liabilities)   $ 9,589,000     $ (175,000 )

 

  

 

As of December 31, 2016, the Company had net operating loss carryforwards for federal income tax purposes of approximately $23,566,000 which will expire at various dates beginning in 2018 and through 2034, and federal research and development tax credits of approximately $464,000, which will expire at various dates beginning in 2018 and through 2036. As of December 31, 2016, the Company had net operating loss carryforwards for state income tax purposes of approximately $13,896,000, which will expire at various dates in 2017 and through 2033, and state research and development tax credits of approximately $291,000, which can be carried forward indefinitely.

 

  The Company has determined that utilization of existing net operating losses against future taxable income is not limited by Section 382 of the Internal Revenue Code. Future ownership changes, however, may limit the Company’s ability to fully utilize its existing net operating loss carryforwards against any future taxable income.

 

A reconciliation of the beginning and ending amount of unrecognized tax benefits (“UTBs”), excluding interest and penalties, is as follows: 

 

    Amount
Beginning balance at January 1, 2016   $ 754,000  
Decreases in UTBs taken in prior years     (38,000 )
Decreases in UTBs taken in current years     39,000  
Ending balance at December 31, 2016   $ 755,000  

 

 

 

Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. It is the Company's policy to include interest and penalties related to tax positions as a component of income tax expense. No interest was accrued for the period ended December 31, 2016. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. 

 

The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which it operates. The Company is not currently under audit in any of its jurisdictions where income tax returns are filed. The tax years 1996 to 2015 remain open to examination by the major domestic taxing jurisdictions to which the Company is subject, and for the years 2003 to 2010 for the international taxing jurisdictions to which the Company is subject.